Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|5|410-423

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.5, 2011-01, pp. : 410-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Central Nervous System as a Promising Target to Treat Diabetes Mellitus

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 19, 2012-10 ,pp. : 2070-2081

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors in Central Nervous System Diseases

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 538-616

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidine: A Potent Candidate for Central Nervous System Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 26-29

Bentham Science Publishers

Access to resources Recommend Favorite

Antibodies As Promising Novel Neuroprotective Agents in the Central Nervous System Injuries

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 8, Iss. 3, 2008-09 ,pp. : 143-169

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HIV Drug Distribution to the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1313-1324

Bentham Science Publishers

Access to resources Recommend Favorite